Abstract
A new HPLC method have been developed and validated for simultaneous determination of carprofen, vitamin B1, B6 and B12 in veterinary pharmaceutical preparations medicines. The method used a Hypersil GOLD aQ (250 x 4.6 mm, 5 µm) column, under the following chromatographic conditions: gradient elution, using a mobile phase composed by phosphate buffer (pH 2.65) and methanol as an organic modifier. The mobile phase was delivered at a flow rate of 1 mL/min and the detection was made by photodiode array (PDA) detector at 292 nm. This method was fully validated and applied on available pharmaceutical product. The limit of detection (LOD) and limit of quantitation (LOQ) for vitamin B1 were 0.5ng/mL and 1.5ng/mL respectively while for vitamin B12 were 1ng/mL and 5ng/mL respectively The main advantages of this HPLC method relies on the possibility to asses in a single run all the above mentioned drugs.
Keywords: Carprofen, vitamin B1, B6 and B12, HPLC, pharmaceutical analysis
Current Analytical Chemistry
Title:Determination of Carprofen in the Presence of some Hydrosoluble Vitamins of Group B by HPLC Method
Volume: 11 Issue: 4
Author(s): Georgeta-Simona Stan, Bianca Elena Mitoi, Andrei Mihaila, Irinel Adriana Badea and Hassan Y. Aboul-Enein
Affiliation:
Keywords: Carprofen, vitamin B1, B6 and B12, HPLC, pharmaceutical analysis
Abstract: A new HPLC method have been developed and validated for simultaneous determination of carprofen, vitamin B1, B6 and B12 in veterinary pharmaceutical preparations medicines. The method used a Hypersil GOLD aQ (250 x 4.6 mm, 5 µm) column, under the following chromatographic conditions: gradient elution, using a mobile phase composed by phosphate buffer (pH 2.65) and methanol as an organic modifier. The mobile phase was delivered at a flow rate of 1 mL/min and the detection was made by photodiode array (PDA) detector at 292 nm. This method was fully validated and applied on available pharmaceutical product. The limit of detection (LOD) and limit of quantitation (LOQ) for vitamin B1 were 0.5ng/mL and 1.5ng/mL respectively while for vitamin B12 were 1ng/mL and 5ng/mL respectively The main advantages of this HPLC method relies on the possibility to asses in a single run all the above mentioned drugs.
Export Options
About this article
Cite this article as:
Stan Georgeta-Simona, Mitoi Elena Bianca, Mihaila Andrei, Badea Adriana Irinel and Aboul-Enein Y. Hassan, Determination of Carprofen in the Presence of some Hydrosoluble Vitamins of Group B by HPLC Method, Current Analytical Chemistry 2015; 11 (4) . https://dx.doi.org/10.2174/1573411011666150326001707
DOI https://dx.doi.org/10.2174/1573411011666150326001707 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Metabolic Syndrome and Adipose Tissue: New Clinical Aspects and Therapeutic Targets
Current Pharmaceutical Design Immune Responses to Adeno-Associated Virus Vectors
Current Gene Therapy Osteoporosis: Current and Emerging Therapies Targeted to Immunological Checkpoints
Current Medicinal Chemistry Nuclear Factor Kappa B is a Promising Therapeutic Target in Inflammatory Lung Disease
Current Drug Targets Treatment of Chronic Hepatitis B in Children
Recent Patents on Anti-Infective Drug Discovery Toll-Like Receptor (TLR) Response Tolerance: A Key Physiological “ Damage Limitation ” Effect and an Important Potential Opportunity for Therapy
Current Medicinal Chemistry Amiloride Alleviates Neurological Deficits Following Transient Global Ischemia and Engagement of Central IL-6 and TNF-α Signal
Current Molecular Medicine Recent Clinical Trials of mTOR-Targeted Cancer Therapies
Reviews on Recent Clinical Trials Medicinal Value and Potential Therapeutic Mechanisms of Gynostemma pentaphyllum (Thunb.) Makino and Its Derivatives: An Overview
Current Topics in Medicinal Chemistry Targeting the Nuclear Transport Machinery by Rational Drug Design
Current Pharmaceutical Design Pharmacophore Modelling as a Virtual Screening Tool for the Discovery of Small Molecule Protein-protein Interaction Inhibitors
Current Pharmaceutical Design “Smart” Nanocarriers: A New Paradigm for Tumor Targeting Drug Delivery Systems
Drug Delivery Letters Drug-Induced Hair Disorders
Current Drug Safety Novel Treatments in Diabetic Nephropathy
Current Hypertension Reviews Local Melatonin Regulates Inflammation Resolution: A Common Factor in Neurodegenerative, Psychiatric and Systemic Inflammatory Disorders
CNS & Neurological Disorders - Drug Targets T-Regulatory Cell Subsets in Children with Type 1 Diabetes Mellitus: Relation to Control of the Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Five Decades of Cuprizone, an Updated Model to Replicate Demyelinating Diseases
Current Neuropharmacology Transcription Factors in Heart: Promising Therapeutic Targets in Cardiac Hypertrophy
Current Cardiology Reviews IL-6 Activated JAK/STAT3 Pathway and Sensitivity to Hsp90 Inhibitors in Multiple Myeloma
Current Medicinal Chemistry The Pathobiology of Endothelin-1 in Vein Graft Disease: Are ETA Receptor Antagonists the Solution to Prevent Vein Graft Failure?
Current Vascular Pharmacology